Health officials have concerns as people nationwide participate in mass gatherings to protest the death of George Floyd; Trump cuts US ties with WHO over handling of coronavirus disease 2019 (COVID-19); former FDA commisioner Scott Gottlieb, MD, says addressing racial inequities in COVID-19 transmission and higher death rates could halt the pandemic.
As protests involving the death of George Floyd continue to grow nationwide, the gathering of mass crowds and responses by law enforcement may threaten efforts by health officials to track and contain the spread of the coronavirus disease 2019 (COVID-19), reported The Associated Press. Contact tracing, which requires infected individuals to remember everyone in contact they have been in with within the past several days, could prove impossible with mass gatherings. In addition, public mistrust of government and police could complicate efforts. However, William Schaffner, MD, an infectious disease expert at Vanderbilt University, notes that as the protests were outside and since many of the people involved wore masks, much of the contact may be less hazardous.
President Donald Trump announced last Friday that the United States will cut ties with the World Health Organization (WHO), citing its handling of the COVID-19 pandemic, according to Reuters. The move follows rising tensions between the Trump administration and China, with Trump saying Chinese officials failed to report the virus as obligated to WHO. The US initially joined WHO in 1948, and currently owes more than $200 million in assessed contributions.
Former FDA Commissioner Scott Gottlieb, MD, noted that addressing underlying problems of racial inequity in the US could halt the COVID-19 pandemic, according to The Hill. Racial inequities amid the pandemic, which has been shown to impact communities of color at disproportionate rates, may be addressed at 2 levels, he said—why there are higher rates of COVID-19, and subsequently, how this leads to higher death rates among black Americans.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen